Trial Profile
A retrospective study assessing the predictors of LDL-C goal attainment with Ezetimibe therapy in patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Jul 2017
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary)
- Indications Atherosclerosis; Cardiovascular disorders; Hypercholesterolaemia
- Focus Therapeutic Use
- 06 Jul 2017 New trial record